In CRC, proliferation is sustained through the epidermal growth factor receptor (EGFR), also known as HER1, as well as through HER2/ERBB2, HER3/ERBB3, and HER4/ERBB4. This evidence concerns the gene ERBB2 and colorectal carcinoma.